BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//KESHO - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:KESHO
X-ORIGINAL-URL:https://kesho-kenya.org
X-WR-CALDESC:Events for KESHO
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Africa/Nairobi
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0300
TZNAME:EAT
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20260226T190000
DTEND;TZID=Africa/Nairobi:20260226T203000
DTSTAMP:20260527T002319
CREATED:20260223T194335Z
LAST-MODIFIED:20260319T173215Z
UID:41036-1772132400-1772137800@kesho-kenya.org
SUMMARY:Precision Pathways in Lymphoma
DESCRIPTION:[vc_row][vc_column][vc_column_text css=””] \nDate: 26th February 2026Time: 7:00 PM – 8:30 PM (EAT) \n\nSpeakers \nModeratorDr Anne MwirigiConsultant Haematologist & Assistant Professor\, AKUH \nDr Rohini RadiaConsultant in BMT and Haematology\, Nairobi West HospitalStrategic Alignment in Lymphoma: From Precise Diagnosis to Clinical Excellence \nDr Jonathan WawireConsultant Anatomic Pathologist & Assistant Professor\, AKUHLymphoma Diagnostic Algorithm in Routine Practice \nHighlights\nThis session explored how lymphoma care is increasingly shaped by the alignment between diagnostic precision and therapeutic decision-making\, particularly in settings where access to advanced diagnostics remains variable. \nA central theme was the shift from morphology-led classification alone to a multi-parameter diagnostic approach\, integrating clinical context\, histopathology\, immunophenotyping and where available\, molecular profiling. As emphasized during the discussion\, classification is no longer purely descriptive: it directly determines treatment pathways\, prognosis and eligibility for emerging therapies. \nDr. Wawire outlined a structured diagnostic framework anchored on architecture\, cytology and clonality\, with morphology guiding the initial pathway and targeted immunohistochemistry refining classification. In routine practice\, a focused IHC panel (CD20\, CD3\, CD5\, CD10\, Cyclin D1) remains sufficient to classify most lymphomas and support timely clinical decisions. \nImportantly\, the session addressed the practical realities of diagnostic limitations. The distinction between “Not Otherwise Specified (NOS)” and “Not Further Classified (NFC)” was highlighted as a clinically responsible approach where molecular testing is unavailable maintaining transparency while ensuring patients are still appropriately managed. \nBuilding on this\, Dr. Radia emphasized that improved outcomes depend on early alignment between diagnostics\, treatment selection and delivery systems. In practice\, delays in diagnostic workflows or limited access to molecular testing can directly influence treatment choices and patient outcomes making coordination across pathology\, oncology and imaging essential. \nAs treatment options expand\, from immunochemotherapy to targeted agents\, CAR-T therapies and bispecific antibodies\, the need for early risk stratification and timely decision-making becomes even more critical\, particularly in balancing efficacy\, cost and access within real-world settings. \nAcross the case discussions\, a consistent message emerged: the quality and timeliness of diagnosis remain central to achieving better outcomes in lymphoma care. \nKey takeaways: \n\nLymphoma classification now relies on integrated clinical\, morphological and molecular assessment.\nFocused IHC panels remain highly effective in routine and resource-limited settings.\n“NFC” supports safe\, transparent reporting when advanced testing is unavailable.\nDiagnostic delays and access gaps can directly impact treatment decisions.\nEarly alignment across disciplines is essential to optimize outcomes.
URL:https://kesho-kenya.org/event/precision-pathways-in-lymphoma/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2026/02/WhatsApp-Image-2026-02-23-at-10.02.59-PM-e1771875762948.jpeg
END:VEVENT
END:VCALENDAR